Brown Advisory Inc. Invests $679,000 in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Brown Advisory Inc. acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 45,464 shares of the medical instruments supplier’s stock, valued at approximately $679,000.

Several other institutional investors and hedge funds also recently made changes to their positions in XRAY. Proficio Capital Partners LLC acquired a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at about $422,000. Raymond James Financial Inc. acquired a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at about $10,335,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of DENTSPLY SIRONA by 35.2% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 58,213 shares of the medical instruments supplier’s stock valued at $1,105,000 after acquiring an additional 15,162 shares in the last quarter. HighTower Advisors LLC boosted its position in shares of DENTSPLY SIRONA by 41.3% during the 4th quarter. HighTower Advisors LLC now owns 24,480 shares of the medical instruments supplier’s stock valued at $465,000 after acquiring an additional 7,152 shares in the last quarter. Finally, Sequoia Financial Advisors LLC boosted its position in shares of DENTSPLY SIRONA by 35.8% during the 4th quarter. Sequoia Financial Advisors LLC now owns 11,556 shares of the medical instruments supplier’s stock valued at $219,000 after acquiring an additional 3,048 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Trading Down 1.3%

Shares of NASDAQ XRAY opened at $16.00 on Tuesday. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $27.95. The company has a market cap of $3.19 billion, a PE ratio of -3.52, a P/E/G ratio of 1.16 and a beta of 0.94. The company has a current ratio of 1.10, a quick ratio of 0.76 and a debt-to-equity ratio of 0.79. The company has a 50-day moving average of $15.94 and a two-hundred day moving average of $16.36.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The company had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. During the same period in the previous year, the firm posted $0.42 earnings per share. The company’s revenue was down 7.8% on a year-over-year basis. As a group, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.00%. The ex-dividend date was Friday, June 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.10%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Morgan Stanley lowered shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 target price on the stock. in a research report on Tuesday, April 15th. Wall Street Zen upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Sunday. Barrington Research boosted their price target on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an “outperform” rating in a research report on Monday, May 12th. UBS Group reduced their price target on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday, May 9th. Finally, Piper Sandler reduced their price target on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 30th. Eleven investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $20.36.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.